CoChat

Effect of BRX‐220 against Peripheral Neuropathy and Insulin Resistance in Diabetic Rat Models

KÜRTHY, MARIA, MOGYORÓSI, TAMÁS, NAGY, KÁROLY, KUKORELLI, TIBOR, JEDNÁKOVITS, ANDREA, TÁLOSI, LÁSZLÓ, BÍRÓ, KATALIN · 2002 · Annals of the New York Academy of Sciences
Cited by 53

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

A bstract: Bimoclomol (BML), a symptomatic antidiabetic agent, has been developed by Biorex R & D Co. to treat diabetic neuropathy and retinopathy. BRX‐220, an orally active member of the BRX family, has been developed to treat diabetic complications and insulin resistance (IR) as a follow‐up compound. The effect of BRX‐220 on peripheral neuropathy was examined in rats with diabetes (type 1) induced by administration of a β‐cell toxin, streptozotocin (STZ, 45 mg/kg iv). Nerve functions were evaluated by electrophysiological measurements of muscle motor and sensory nerve conduction velocities (MNCV and SNCV, respectively). MNCV and SNCV decreased in diabetic rats by 25% (p < 0.001). A 1‐month preventive treatment with BRX‐220 (2.5, 5, 10, and 20 mg/kg po) dose‐dependently improved diabetes‐related deficits in MNCV (51.3%, 71.3%, 86.1%, and 91.3%) and SNCV (48.9%, 68.5%, 86.1%, and 93.2%). Insulin sensitivity was measured using the insulin tolerance test (ITT), both in STZ diabetic and in Zucker diabetic fatty (ZDF) rats (model of type 2 diabetes). Severe IR was detected in STZ diabetic and ZDF rats. This resistance was significantly (p < 0.05) reduced by BRX‐220 treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2002.tb04306.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 53

Metadata

Authors
KÜRTHY, M., MOGYORÓSI, T., NAGY, K., KUKORELLI, T., JEDNÁKOVITS, A., TÁLOSI, L., & BÍRÓ, K.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2002-06
Volume
967
Issue
1
Pages
482-489
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2102667122
Cited by
53
References
1
FWCI
1.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of BRX‐220 against Peripheral Neuropathy and Insulin Resistance in Diabetic Rat Models. https://app.cochat.ai/papers/10.1111/j.1749-6632.2002.tb04306.x
The paper
KÜRTHY, M., MOGYORÓSI, T., NAGY, K., KUKORELLI, T., JEDNÁKOVITS, A., TÁLOSI, L., & BÍRÓ, K. (2002). Effect of BRX‐220 against Peripheral Neuropathy and Insulin Resistance in Diabetic Rat Models. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2002.tb04306.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.